- Home
- INLX vs DXR Comparison
INLX vs DXR Comparison
Compare INLX & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INLX
- DXR
- Stock Information
- Founded
- INLX 1996
- DXR 1970
- Country
- INLX United States
- DXR United States
- Employees
- INLX N/A
- DXR N/A
- Industry
- INLX EDP Services
- DXR Medical/Dental Instruments
- Sector
- INLX Technology
- DXR Health Care
- Exchange
- INLX Nasdaq
- DXR Nasdaq
- Market Cap
- INLX 40.8M
- DXR 46.9M
- IPO Year
- INLX N/A
- DXR N/A
- Fundamental
- Price
- INLX $11.00
- DXR $13.50
- Analyst Decision
- INLX
- DXR Strong Buy
- Analyst Count
- INLX 0
- DXR 1
- Target Price
- INLX N/A
- DXR $25.00
- AVG Volume (30 Days)
- INLX 6.6K
- DXR 5.1K
- Earning Date
- INLX 11-12-2025
- DXR 01-01-0001
- Dividend Yield
- INLX N/A
- DXR N/A
- EPS Growth
- INLX N/A
- DXR 3.46
- EPS
- INLX N/A
- DXR 0.36
- Revenue
- INLX $17,127,854.00
- DXR $66,306.00
- Revenue This Year
- INLX N/A
- DXR N/A
- Revenue Next Year
- INLX $14.19
- DXR N/A
- P/E Ratio
- INLX N/A
- DXR $38.30
- Revenue Growth
- INLX N/A
- DXR N/A
- 52 Week Low
- INLX $8.74
- DXR $6.55
- 52 Week High
- INLX $16.50
- DXR $14.00
- Technical
- Relative Strength Index (RSI)
- INLX 43.78
- DXR 66.65
- Support Level
- INLX $11.11
- DXR $13.39
- Resistance Level
- INLX $11.55
- DXR $14.00
- Average True Range (ATR)
- INLX 0.12
- DXR 0.50
- MACD
- INLX -0.08
- DXR 0.13
- Stochastic Oscillator
- INLX 21.28
- DXR 80.93
About INLX Intellinetics Inc.
Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.